• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

等待尸体供肾移植的终末期肾病患者的结局:一项单中心研究。

Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study.

作者信息

Jeon Hong Jae, Bae Hong Jin, Ham Young Rok, Choi Dae Eun, Na Ki Ryang, Ahn Moon-Sang, Lee Kang Wook

机构信息

Division of Nephrology, Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Korea.

Department of Surgery, Chungnam National University Hospital, Daejeon, Korea.

出版信息

Kidney Res Clin Pract. 2019 Mar 31;38(1):116-123. doi: 10.23876/j.krcp.18.0068.

DOI:10.23876/j.krcp.18.0068
PMID:30743320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6481973/
Abstract

BACKGROUND

Kidney transplantation is an effective renal replacement therapy for patients with end-stage renal disease (ESRD). In this study, we assessed the impact of the baseline characteristics and comorbidities of ESRD patients on the probability of deceased donor kidney transplantation (DDKT) and evaluated the morbidity and mortality during the time spent waiting.

METHODS

The study population consisted of 544 ESRD patients on the waiting list for DDKT at Chungnam National University Hospital in South Korea between February 2000 and October 2015. The patients were observed from the date of transplantation list registration to the date of transplantation. Baseline characteristics and comorbidities were investigated together with new-onset comorbidities that occurred during the waiting time.

RESULTS

Diabetes mellitus (39.0%), hypertension (25.2%), and glomerulonephritis (21.3%) were the three most common causes of ESRD in this study, and coronary artery disease (9.4%) was the most common comorbidity. The 115 patients (19.3%) who underwent DDKT had a mean waiting time of 1,711 days (768-2,654 days or 4.68 years [2.10-7.27]). Blood groups other than type O, peritoneal dialysis, and nondiabetic ESRD were significantly associated with a higher likelihood of DDKT. Infection was the leading cause of death and the most common comorbidity that arose during the waiting time. Patients who experienced cardiovascular events during the waiting time showed a lower transplant rate compared with those who did not.

CONCLUSION

The prevalence of comorbidities was high in renal transplantation candidates. During the often-long waiting time, new comorbidities may occur, with long-term sequelae limiting access to kidney transplantation or resulting in death.

摘要

背景

肾移植是终末期肾病(ESRD)患者有效的肾脏替代治疗方法。在本研究中,我们评估了ESRD患者的基线特征和合并症对尸体供肾移植(DDKT)概率的影响,并评估了等待期间的发病率和死亡率。

方法

研究人群包括2000年2月至2015年10月在韩国忠南国立大学医院等待DDKT的544例ESRD患者。从移植名单登记日期到移植日期对患者进行观察。调查基线特征、合并症以及等待期间出现的新发合并症。

结果

糖尿病(39.0%)、高血压(25.2%)和肾小球肾炎(21.3%)是本研究中ESRD的三大最常见病因,冠状动脉疾病(9.4%)是最常见的合并症。接受DDKT的115例患者(19.3%)平均等待时间为1711天(768 - 2654天或4.68年[2.10 - 7.27])。非O型血、腹膜透析和非糖尿病性ESRD与更高的DDKT可能性显著相关。感染是死亡的主要原因,也是等待期间出现的最常见合并症。等待期间发生心血管事件的患者与未发生的患者相比,移植率较低。

结论

肾移植候选者中合并症的患病率较高。在通常漫长的等待时间里,可能会出现新的合并症,其长期后果会限制肾移植的机会或导致死亡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d8/6481973/3a7be881eadf/krcp-38-116f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d8/6481973/3a7be881eadf/krcp-38-116f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26d8/6481973/3a7be881eadf/krcp-38-116f1.jpg

相似文献

1
Outcomes of end-stage renal disease patients on the waiting list for deceased donor kidney transplantation: A single-center study.等待尸体供肾移植的终末期肾病患者的结局:一项单中心研究。
Kidney Res Clin Pract. 2019 Mar 31;38(1):116-123. doi: 10.23876/j.krcp.18.0068.
2
Cardiovascular risk trajectory and its associated factors among candidates on the waiting list for deceased-donor kidney transplantation: A longitudinal study.等待接受已故供体肾移植患者的心血管风险轨迹及其相关因素:一项纵向研究。
Heart Lung. 2024 Jan-Feb;63:114-118. doi: 10.1016/j.hrtlng.2023.10.008. Epub 2023 Oct 21.
3
Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time.与等待移植或长时间等待的HLA配型相合的 deceased 供体肾移植相比,HLA配型不相合的活体供体肾移植具有生存获益。 (注:这里“deceased donor”直译为“已故供体”,在医学移植领域常表述为“尸体供体” )
Kidney Int. 2021 Jul;100(1):206-214. doi: 10.1016/j.kint.2021.01.027. Epub 2021 Feb 26.
4
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
5
The experiences of adults who are on dialysis and waiting for a renal transplant from a deceased donor: a systematic review.接受透析治疗并等待已故捐赠者肾脏移植的成年人的经历:一项系统综述。
JBI Database System Rev Implement Rep. 2015 Mar 12;13(2):169-211. doi: 10.11124/jbisrir-2015-1973.
6
Trends in Patient Characteristics on the Japanese Waiting Lists for Deceased-Donor Kidney Transplantation. Are There no Eligibility or Ineligibility Criteria for Registration and Renewal?日本遗体捐献者肾脏移植候补患者特征趋势。注册和更新是否没有资格或无资格标准?
Transplant Proc. 2024 Oct;56(8):1721-1731. doi: 10.1016/j.transproceed.2024.08.029. Epub 2024 Sep 3.
7
[Evaluation and selection of candidates for renal transplantation at the Clinical Hospital Center in Rijeka].[里耶卡临床医院中心肾移植候选人的评估与选择]
Acta Med Croatica. 2003;57(1):65-8.
8
Outcomes of dialysis and the transplantation options for patients with diabetic end-stage renal disease in Korea.韩国糖尿病终末期肾病患者的透析结果及移植选择
Clin Transplant. 2016 May;30(5):534-44. doi: 10.1111/ctr.12719. Epub 2016 Mar 11.
9
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.
10
Factors Associated With Waiting Time to Deceased Donor Kidney Transplantation in Transplant Candidates.移植候选者中与等待死亡供体肾移植时间相关的因素。
Transplant Proc. 2018 May;50(4):1041-1044. doi: 10.1016/j.transproceed.2018.02.038.

引用本文的文献

1
Cardiovascular disease in waitlisted hemodialyzed patients.等待透析的血液透析患者的心血管疾病
Ren Fail. 2024 Dec;46(2):2440511. doi: 10.1080/0886022X.2024.2440511. Epub 2024 Dec 17.
2
Peritoneal dialysis versus haemodialysis for people commencing dialysis.腹膜透析与血液透析治疗开始透析的患者。
Cochrane Database Syst Rev. 2024 Jun 20;6(6):CD013800. doi: 10.1002/14651858.CD013800.pub2.
3
Pros and cons of live kidney donation in prediabetics: A critical review and way forward.糖尿病前期患者活体肾捐赠的利弊:一项批判性综述及未来方向

本文引用的文献

1
Association of Candidate Removals From the Kidney Transplant Waiting List and Center Performance Oversight.从肾移植等候名单中移除候选人与中心绩效监督的关联
Am J Transplant. 2016 Apr;16(4):1276-84. doi: 10.1111/ajt.13594. Epub 2016 Jan 14.
2
Screening for cardiovascular disease before kidney transplantation.肾移植前的心血管疾病筛查。
World J Transplant. 2015 Dec 24;5(4):276-86. doi: 10.5500/wjt.v5.i4.276.
3
Risk factors for cardiovascular events among Asian patients without pre-existing cardiovascular disease on the renal transplant wait list.
World J Transplant. 2024 Mar 18;14(1):89822. doi: 10.5500/wjt.v14.i1.89822.
4
Incident dementia in kidney transplantation recipients: a matched comparative nationwide cohort study in South Korea.肾移植受者的新发痴呆症:韩国一项全国性配对比较队列研究。
Kidney Res Clin Pract. 2023 Jul;42(4):519-530. doi: 10.23876/j.krcp.21.182. Epub 2023 Jul 28.
5
Long-term end-stage renal disease risks after living kidney donation: a systematic review and meta-analysis.活体肾捐献后长期终末期肾病风险:系统评价和荟萃分析。
BMC Nephrol. 2023 May 30;24(1):152. doi: 10.1186/s12882-023-03208-z.
6
Changes in socioeconomic status and patient outcomes in kidney transplantation recipients in South Korea.韩国肾移植受者社会经济状况的变化及患者预后
Korean J Transplant. 2023 Mar 31;37(1):29-40. doi: 10.4285/kjt.22.0049. Epub 2023 Mar 24.
7
Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation.供受者肥胖合并与肾移植后移植物丢失的风险。
Transpl Int. 2022 Sep 29;35:10656. doi: 10.3389/ti.2022.10656. eCollection 2022.
8
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden.肾移植后的心血管风险:病因及应对相关负担的当前方法
J Pers Med. 2022 Jul 23;12(8):1200. doi: 10.3390/jpm12081200.
9
Omics-based biomarkers for diagnosis and prediction of kidney allograft rejection.基于组学的生物标志物用于诊断和预测肾移植排斥反应。
Korean J Intern Med. 2022 May;37(3):520-533. doi: 10.3904/kjim.2021.518. Epub 2022 Apr 15.
10
Elderly kidney transplant recipients have favorable outcomes but increased infection-related mortality.老年肾移植受者有良好的预后,但与感染相关的死亡率增加。
Kidney Res Clin Pract. 2022 May;41(3):372-383. doi: 10.23876/j.krcp.21.207. Epub 2022 Feb 23.
肾移植等待名单上无心血管疾病史的亚洲患者发生心血管事件的危险因素。
ASEAN Heart J. 2015;23(1):1. doi: 10.7603/s40602-015-0001-0.
4
Mortality on a renal transplantation waiting list.肾移植等待名单上的死亡率。
Nefrologia. 2015;35(1):18-27. doi: 10.3265/Nefrologia.pre2014.Oct.12681.
5
Impact of patient characteristics and comorbidity profile on activation of patients on the kidney transplantation waiting list.
Transplant Proc. 2013 Jul-Aug;45(6):2115-22. doi: 10.1016/j.transproceed.2013.03.033.
6
Prognostic factors of coronary heart disease in asymptomatic diabetics for inclusion on the kidney transplant waiting list. Screening with coronary angiography.无症状糖尿病患者冠状动脉心脏病的预后因素纳入肾移植等待名单。冠状动脉造影筛查。
Nefrologia. 2012 Jul 17;32(4):502-7. doi: 10.3265/Nefrologia.pre2012.Apr.11355.
7
Cardiac disease evaluation and management among kidney and liver transplantation candidates: a scientific statement from the American Heart Association and the American College of Cardiology Foundation.肾移植和肝移植候选者的心脏病评估与管理:美国心脏协会和美国心脏病学基金会的科学声明
J Am Coll Cardiol. 2012 Jul 31;60(5):434-80. doi: 10.1016/j.jacc.2012.05.008. Epub 2012 Jul 2.
8
Access to renal transplantation in the diabetic population-effect of comorbidities and body mass index.糖尿病患者接受肾移植的途径——合并症和体重指数的影响。
Clin Transplant. 2012 May-Jun;26(3):E307-15. doi: 10.1111/j.1399-0012.2012.01661.x.
9
Systematic review: kidney transplantation compared with dialysis in clinically relevant outcomes.系统评价:临床相关结局的肾移植与透析比较。
Am J Transplant. 2011 Oct;11(10):2093-109. doi: 10.1111/j.1600-6143.2011.03686.x. Epub 2011 Aug 30.
10
The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.慢性肾脏病、终末期肾病以及透析第一年的发病率和死亡率状况。
Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S5-11. doi: 10.2215/CJN.05980809.